Kennedy Opens Door to Six Unapproved Peptides Over FDA Scientists’ Objections
The US health secretary’s draft policy would let licensed pharmacies compound six wellness peptides that have never been approved, despite warnings from the FDA’s own scientists that the evidence behind them is too thin.